1 completed, 1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Melanoma (Excluding Uveal Melanoma): new trials by email Literature Review of Melanoma (Excluding Uveal Melanoma) trials Research Report on Melanoma (Excluding Uveal Melanoma)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma Tumor Tissue Sampling, Lymphodepletion Conditioning, Infusion of HS-IT101 Injection - Melanoma (Excluding Uveal Melanoma) | Phase 2 | Not yet recruiting | Hangzhou Huasai Biomedicine Co., Ltd. | 90 | 2026-02-26 | 2026-02-12 |
| A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) XmAb®23104, Yervoy® (ipilimumab) - Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma | Phase 1 | Completed | Xencor, Inc. | 198 | 2019-05-01 | 2024-07-05 |
Melanoma (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Head and Neck Neoplasms (1) · Histiocytoma, Malignant Fibrous (1) · Liver Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Pancreatic Neoplasms (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Nevi and Melanomas (2) · Skin Diseases (2) · Skin Neoplasms (2) · Skin and Connective Tissue Diseases (2) · Adenocarcinoma (1) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1)
Ipilimumab (1) · Therapeutics (1) · Toll-Like Receptor 1 (1)
Hangzhou Huasai Biomedicine Co., Ltd. (1) · Xencor, Inc. (1)
United States (1)